News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
84,007 Results
Type
Article (9140)
Company Profile (32)
Press Release (74834)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (20911)
Career Advice (930)
Deals (3799)
Drug Delivery (47)
Drug Development (11169)
Employer Resources (57)
FDA (1941)
Job Trends (1856)
News (37532)
Policy (3640)
Tag
Academia (480)
Accelerated approval (10)
Adcomms (15)
Allergies (28)
Alliances (4706)
ALS (35)
Alzheimer's disease (352)
Antibody-drug conjugate (ADC) (33)
Approvals (1860)
Artificial intelligence (110)
Autoimmune disease (28)
Automation (6)
Bankruptcy (35)
Best Places to Work (1474)
BIOSECURE Act (7)
Biosimilars (24)
Biotechnology (27)
Bladder cancer (24)
Brain cancer (13)
Breast cancer (97)
Cancer (596)
Cardiovascular disease (79)
Career advice (761)
Career pathing (13)
CAR-T (45)
CDC (14)
Cell therapy (112)
Cervical cancer (6)
Clinical research (9492)
Collaboration (161)
Compensation (31)
Complete response letters (19)
COVID-19 (708)
CRISPR (8)
C-suite (123)
Cystic fibrosis (17)
Data (1011)
Decentralized trials (1)
Denatured (1)
Depression (49)
Diabetes (114)
Diagnostics (1521)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (41)
Drug pricing (78)
Drug shortages (10)
Duchenne muscular dystrophy (66)
Earnings (10042)
Editorial (26)
Employer branding (7)
Employer resources (52)
Events (8733)
Executive appointments (116)
FDA (2404)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (6)
Frontotemporal dementia (4)
Funding (184)
Gene editing (27)
Generative AI (11)
Gene therapy (132)
GLP-1 (265)
Government (829)
Grass and pollen (2)
Guidances (107)
Healthcare (2521)
HIV (11)
Huntington's disease (11)
IgA nephropathy (23)
Immunology and inflammation (73)
Immuno-oncology (12)
Indications (6)
Infectious disease (762)
Inflammatory bowel disease (26)
Inflation Reduction Act (6)
Influenza (19)
Intellectual property (18)
Interviews (198)
IPO (1841)
IRA (21)
Job creations (415)
Job search strategy (598)
JPM (35)
Kidney cancer (4)
Labor market (32)
Layoffs (123)
Leadership (18)
Legal (668)
Liver cancer (7)
Longevity (2)
Lung cancer (74)
Lymphoma (30)
Machine learning (10)
Management (20)
Manufacturing (126)
MASH (31)
Medical device (1747)
Medtech (1755)
Mergers & acquisitions (2074)
Metabolic disorders (309)
Multiple sclerosis (25)
NASH (3)
Neurodegenerative disease (85)
Neuropsychiatric disorders (35)
Neuroscience (636)
Neurotech (1)
NextGen: Class of 2026 (933)
Non-profit (529)
Now hiring (4)
Obesity (171)
Opinion (128)
Ovarian cancer (14)
Pain (38)
Pancreatic cancer (41)
Parkinson's disease (47)
Partnered (15)
Patents (41)
Patient recruitment (47)
Peanut (8)
People (5675)
Pharmaceutical (2)
Pharmacy benefit managers (14)
Phase 1 (2283)
Phase 2 (4344)
Phase 3 (3763)
Pipeline (854)
Policy (117)
Postmarket research (352)
Preclinical (836)
Press Release (2)
Prostate cancer (25)
Psychedelics (26)
Radiopharmaceuticals (49)
Rare diseases (185)
Real estate (459)
Recruiting (28)
Regulatory (2846)
Reports (9)
Research institute (356)
Resumes & cover letters (188)
Rett syndrome (3)
RNA editing (4)
RSV (18)
Schizophrenia (53)
Series A (29)
Series B (17)
Sickle cell disease (17)
Special edition (7)
Spinal muscular atrophy (44)
Sponsored (17)
Startups (438)
Stomach cancer (6)
Supply chain (18)
Tariffs (31)
The Weekly (9)
Vaccines (194)
Venture capital (27)
Weight loss (135)
Women's health (15)
Worklife (8)
Date
Today (3)
Last 7 days (91)
Last 30 days (331)
Last 365 days (4036)
2026 (412)
2025 (3997)
2024 (4491)
2023 (4912)
2022 (9974)
2021 (9567)
2020 (8884)
2019 (5802)
2018 (4403)
2017 (3957)
2016 (3581)
2015 (4128)
2014 (2874)
2013 (1896)
2012 (2164)
2011 (2252)
2010 (1780)
Location
Africa (227)
Alabama (3)
Alaska (1)
Arizona (15)
Arkansas (5)
Asia (3477)
Australia (1013)
California (1290)
Canada (386)
China (126)
Colorado (45)
Connecticut (89)
Delaware (25)
Europe (9806)
Florida (153)
Georgia (30)
Idaho (10)
Illinois (96)
India (5)
Indiana (63)
Iowa (2)
Japan (35)
Kansas (12)
Kentucky (3)
Louisiana (1)
Maine (10)
Maryland (190)
Massachusetts (1114)
Michigan (92)
Minnesota (49)
Mississippi (1)
Missouri (27)
Montana (2)
Nebraska (3)
Nevada (19)
New Hampshire (12)
New Jersey (262)
New Mexico (3)
New York (339)
North Carolina (143)
Northern California (545)
Ohio (36)
Oklahoma (4)
Oregon (5)
Pennsylvania (262)
Rhode Island (3)
South America (251)
South Carolina (4)
Southern California (557)
Tennessee (16)
Texas (181)
United States (4633)
Utah (87)
Virginia (31)
Washington D.C. (12)
Washington State (61)
West Virginia (2)
Wisconsin (11)
84,007 Results for "point biopharma.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Psychedelics
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
With Lykos’ regulatory failure now squarely in the rearview mirror, Compass Pathways and Definium are leading what one analyst suspects will be “a very big year for psychedelics.”
February 2, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Variable Rate of Anticoagulation Response to Direct Oral Anticoagulants (DOACs) in Acute Ischemic Stroke: The Potential of Point-of-Care DOAC Anticoagulation Measurement
February 5, 2026
·
4 min read
Alzheimer’s disease
I Remember Aduhelm. The Return of Roche in Alzheimer’s Is a Turning Point
After covering the Alzheimer’s space through every high and low,
BioSpace
’s Annalee Armstrong welcomes back Roche for the 2026 Alzheimer’s Renaissance.
December 2, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation
January 16, 2026
·
5 min read
Press Releases
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
February 3, 2026
·
6 min read
Earnings
GSK Points to ‘Macro Factors’ To Explain US Shingrix Demand Crash
Shingrix sales in the U.S. took a 15% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales, after
Sanofi reported
a similar decline last week.
October 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Life Sciences at a Turning Point: GenAI, Digital Health, and Precision Therapies Ignite a New Era of Hyper-Growth
November 25, 2025
·
1 min read
Press Releases
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
December 18, 2025
·
4 min read
Press Releases
Natus announces FDA 510(k) clearance for electrographic status epilepticus diagnostic indication in BrainWatch point-of-care EEG solution
December 4, 2025
·
3 min read
Press Releases
SimplyTest Partners with Evexia Diagnostics to Expand Access to PERIO and 4-Point Cortisol Tests for Functional and Integrative Health Practitioners
November 4, 2025
·
3 min read
1 of 8,401
Next
